BioTrinity is Europe’s leading investment and bio-partnering conference and provides a unique platform for companies across the life sciences industry to achieve their business objectives, secure...
Black Swan Analysis Blog
Black Swan Analysis is attending the BioTrinity Conference: Vision for Life Sciences 2030, London on the 25th – 27th April
A look into...Coronary Heart Disease
Coronary heart disease (CHD) is the leading cause of death both in the UK and worldwide. CHD generally affects more men than women, but both are at higher risk as age increases. The disease occurs...
Forecasting in Dynamic Oncology Markets
Two big things struck me as interesting during an Innovations in Oncology Conference in Edinburgh this month. Firstly how exciting the market is right now, with many productive collaborations...
Rare talent at finding rare information
There’s no common worldwide definition of what constitutes a rare disease. The European Commission on Public Health defines rare diseases as "life-threatening or chronically debilitating diseases...
A look into...Fabry Disease
Fabry disease is caused by a mutation in the alpha-galactosidase-A gene (GLA). This gene codes for an enzyme active in lysosomes, the recycling centres within cells. Lysosomes contain more than 50...
Shire bets big on rare diseases
Speciality pharma firm Shire has agreed to buy Baxalta for around $32 billion (£22 billion), to further expand its portfolio of treatments for rare diseases. Baxalta, the spun-off pharmaceutical...
Black Swan Analysis short-listed for the “Management Team of the Year” category at this year’s Thames Valley Business Awards
Black Swan Analysis has just been short-listed for the “The Management Team of the Year Award” sponsored by NatWest and open to outstanding management teams in the Thames Valley. We are joined on the...
Black Swan Analysis short-listed for the “Micro Business of the Year” category at this year’s National Growing Business Awards
Black Swan Analysis has been shortlisted for the Micro Business of the Year category, for this year’s Growing Business Awards, in association with Lloyds Bank, supported by Real Business and the CBI....
A look into...Sickle Cell Disease
Although Sickle Cell Disease (SCD) is the most frequent haemoglobinopathy worldwide, it remains a rare blood disorder in most western countries. Globally, an estimated 5% of the world’s population...